European Archives - Page 945 of 1641 - European Medical Journal

The Need to Focus on Biopreparedness

This webinar covers the importance of both prevention and preparing for biothreats. Through highlighting outbreaks such as COVID-19, mpox (formerly monkeypox), respiratory syncytial virus, and Ebola, the presentation explores the challenges faced, lessons learned, and discusses how to better prepare for future outbreaks.

Interview: Samin Sharma

EMJ spoke to Samin Sharma about the Eternal Heart Care Centre (EHCC), percutaneous coronary intervention, and advances in the field…

You Are What You Eat

This episode discusses the impact of plant-based diets in kidney disease, as well as other dietary interventions to prevent disease.

From CoNFLict to Confidence: Solving a Diagnostic Dilemma Using Neurofilament Light – A Case Report

Measurement of fluid biomarkers of neurodegeneration is an emerging approach offering improved diagnostic accuracy of neuropsychiatric conditions, particularly for atypical presentations. This article reports a case where the diagnosis of delirium with dementia was revised based on biomarker analysis, enabling treatment of a primary mood disorder with resolution of recurrent disabling psychiatric symptoms.

Is medical affairs the Ferrari of the pharma industry?

In this episode, Isabel chats with Bora Erdemli, Associate Principal and Leader of Medical Affairs Practice, Europe, ZS.

First Francisella novicida Case Report in Argentina

A 38-year-old male with a right cervical mass, fever, and sweating was admitted to the authors’ hospital in 2020. The patient had no weight loss or asthenia.

Update on AL Amyloidosis

This webinar discusses the critical factors involved in amyloidosis diagnosis, prognosis and management, describing both haematologic and organ responses to treatment. The presentation also delves into the origins of cardiac amyloidosis, outlining investigations required to assess organ involvement and establish a diagnosis.

NUVAXOVIDᵀᴹ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) For Individuals 12 Years and Older - Switzerland

Learn about the clinical efficacy and safety data for a new recombinant protein subunit COVID-19 vaccine approved and available.

Interview: Peter Gill

Peter Gill | Staff Paediatrician and Associate Scientist, The Hospital for Sick Children and SickKids Research Institute, Toronto, Canada; Assistant Professor, Department of Paediatrics and Institute of Health Policy, Management and Evaluation, University of Toronto, Canada

Interview: Damian Roland

Damian Roland | Head of Service, Children’s Emergency Department, Leicester Royal Infirmary, UK; Honorary Professor, Population Health Sciences, University of Leicester, UK